DMK PHARMACEUTICALS CORPORATION Increase (Decrease) in Other Operating Liabilities
DMK PHARMACEUTICALS CORPORATION reported Increase (Decrease) in Other Operating Liabilities of -$7.90 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2023-03-16
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other operating liabilities for the quarter ending 2021-12-31 was $0.00.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other operating liabilities for the quarter ending 2021-09-30 was $0.00.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other operating liabilities for fiscal 2021 was -$7.90M, a 200.00% decline from fiscal 2020.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other operating liabilities for fiscal 2020 was $7.90M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | -$7.90M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | -$7.90M 10-Q · filed 2021-11-22 | ||
| 2021-06-30 | -$7.90M 10-Q · filed 2021-11-22 | |||
| 2020-12-31 | $7.90M 10-K · filed 2022-03-31 |